Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Hepatic sarcoidosis complicating treatment-naive viral hepatitis.

Aravinthan A, Gelson W, Limbu A, Brais R, Richardson P.

World J Hepatol. 2012 Dec 27;4(12):402-5. doi: 10.4254/wjh.v4.i12.402.

2.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
3.

Management of chronic hepatitis B virus infection: a new era of disease control.

Farrell GC, Teoh NC.

Intern Med J. 2006 Feb;36(2):100-13. Review.

PMID:
16472264
4.

Therapy of viral hepatitis.

Hoofnagle JH.

Digestion. 1998 Aug;59(5):563-78. Review.

PMID:
9705540
5.

Management issues in chronic viral hepatitis: hepatitis C.

Sievert W.

J Gastroenterol Hepatol. 2002 Apr;17(4):415-22. Review.

PMID:
11982722
6.
7.

[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients].

Nicolardi E, Grieco A, Rapaccini GL, Pompili M.

G Ital Nefrol. 2010 May-Jun;27(3):262-73. Review. Italian.

PMID:
20540019
8.

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.

Liver Transpl. 2004 Feb;10(2):199-207.

9.

GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.

Pawlotsky JM, Roudot-Thoraval F, Muerhoff AS, Pellerin M, Germanidis G, Desai SM, Bastie A, Darthuy F, Rémiré J, Zafrani ES, Soussy CJ, Mushahwar IK, Dhumeaux D.

J Med Virol. 1998 Jan;54(1):26-37.

PMID:
9443106
10.

Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.

Di Marco V, Ferraro D, Almasio P, Vaccaro A, Parisi P, Cappello M, Cino N, Di Stefano R, Craxì A.

J Viral Hepat. 2002 Sep;9(5):354-9.

PMID:
12225330
11.

Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.

Kumar R, Singla V, Kacharya Sk.

Trop Gastroenterol. 2008 Jul-Sep;29(3):136-47. Review.

PMID:
19115605
12.

[Treatment and prevention of viral hepatitis].

Palmović D.

Lijec Vjesn. 2004 Sep-Oct;126(9-10):254-60. Review. Croatian.

PMID:
15918324
13.

Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.

Bonny C, Fontaine H, Poynard T, Hézode C, Larrey D, Marcellin P, Bourlière M, Bronowicki JP, Merle P, Zarski JP, Sapey T, Guillemard C, Ughetto S, Henquell C, Nicolas C, Roche C, Randl K, Bommelaer G, Abergel A.

Aliment Pharmacol Ther. 2006 Aug 15;24(4):593-600. Erratum in: Aliment Pharmacol Ther. 2006 Oct 15;24(8):1268.

14.

Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.

Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.

Antivir Ther. 2005;10(1):125-33.

PMID:
15751770
15.

Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.

Chu CJ, Lee SD.

J Gastroenterol Hepatol. 2008 Apr;23(4):512-20. doi: 10.1111/j.1440-1746.2008.05384.x. Review.

PMID:
18397482
16.

Chronic hepatitis C virus infection in renal transplant: treatment and outcome.

Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.

Clin Transplant. 2006 Nov-Dec;20(6):677-83.

PMID:
17100715
17.

Delayed enhanced hepatosplenic sarcoid nodules on computed tomography in an interferon-naïve hepatitis C patient: a case report and review of the literature.

Ugajin T, Miyatani H, Matsuura K, Ushimaru S, Omoto K, Nokubi M, Ohkohchi T, Yoshida Y.

Clin J Gastroenterol. 2012 Dec;5(6):398-406. doi: 10.1007/s12328-012-0337-y. Epub 2012 Oct 13.

PMID:
26181321
18.

Direct acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome.

Sahebjam F, Hajdu CH, Nortey E, Sigal SH.

World J Hepatol. 2016 May 18;8(14):632-6. doi: 10.4254/wjh.v8.i14.632.

19.

[Liver involvement in systemic diseases].

Geri G, Saadoun D, Cacoub P.

Rev Med Interne. 2011 Aug;32(8):486-93. doi: 10.1016/j.revmed.2010.07.008. Epub 2010 Oct 9. Review. French.

PMID:
20934791
20.

Sustained viral response and hematological adverse events during chronic hepatitis C infection treatment.

El-Shabrawi M, Isa M.

Hepat Mon. 2012 Feb;12(2):122-3. doi: 10.5812/hepatmon.831. Epub 2012 Feb 29. No abstract available.

Supplemental Content

Support Center